Gametocytocidal and Transmission-blocking Efficacy of PQ in Combination With AL and TQ in Combination With SPAQ in Mali

PHASE2CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

October 12, 2021

Primary Completion Date

December 16, 2021

Study Completion Date

January 13, 2022

Conditions
Malaria,Falciparum
Interventions
DRUG

Artemether-lumefantrine

Tablets containing 20/80 mg artemether and 120/480 mg lumefantrine will be administered according to weight as per manufacturer guidelines.

DRUG

Primaquine Phosphate

The single dose of 0.25mg/kg PQ will be administered in an aqueous solution, according to a standard operating procedure (SOP) provided by the manufacturer.

DRUG

Sulphadoxine-pyrimethamine with amodiaquine

Sulfadoxine/pyrimethamine tablets contain 500mg sulfadoxine and 25mg pyrimethamine. Amodiaquine tablets contain 150mg amodiaquine (as hydrochloride). Tablets will be administered according to weight as per manufacturer guidelines.

DRUG

Tafenoquine

100mg tafenoquine tablets are prepared into a 1mg/mL solution in water. Solution will be given according to weight as indicated per treatment arm in 5kg bands.

Trial Locations (1)

Unknown

Malaria Research and Training Centre, Bamako

All Listed Sponsors
lead

London School of Hygiene and Tropical Medicine

OTHER

NCT05081089 - Gametocytocidal and Transmission-blocking Efficacy of PQ in Combination With AL and TQ in Combination With SPAQ in Mali | Biotech Hunter | Biotech Hunter